Guangdong Transtek Medical Electronics (300562.SZ) has changed its stock abbreviation to Lexin Co., Ltd.
Lexin Medical (300562.SZ) issued an announcement stating that under the current business structure, medical devices are only one component of the company's operations. The original stock abbreviation Lexin Medical cannot fully encompass the companys existing business content. Based on the actual business composition and future overall strategic development plan of the company, and to more objectively and comprehensively reflect the companys operating status and development strategy, facilitating accurate understanding of the company's business layout and development direction by investors and relevant partners, the company will change its stock abbreviation from Lexin Medical to Lexin Co., Ltd. The effective date of the stock abbreviation change is September 9, 2026 (Wednesday).
Guangdong Transtek Medical Electronics (300562.SZ) announced that medical devices are only one component of the company's current business structure, and the original securities abbreviation "Guangdong Transtek Medical Electronics" cannot fully cover the existing business content of the company. Based on the actual business composition of the company and the overall strategic development plan for the future, in order to more objectively and completely reflect the company's operational status and development strategy, and to facilitate investors and relevant partners in accurately understanding the company's business layout and development direction, the company will change its securities abbreviation from "Guangdong Transtek Medical Electronics" to "". The new securities abbreviation will take effect on September 9, 2026 (Wednesday).
Related Articles
On September 8, ABBISKO-B (02256) repurchased 30,000 shares at a cost of approximately HKD 265,000.
.png)
GCL Energy Technology (002015.SZ) subsidiary plans to invest 100 million yuan to participate in the Lishi Xing Shen Fund.
China Merchants Bank (03968): Zhang Yong's qualification to serve as an independent non-executive director has been approved.
On September 8, ABBISKO-B (02256) repurchased 30,000 shares at a cost of approximately HKD 265,000.
GCL Energy Technology (002015.SZ) subsidiary plans to invest 100 million yuan to participate in the Lishi Xing Shen Fund.
China Merchants Bank (03968): Zhang Yong's qualification to serve as an independent non-executive director has been approved.
RECOMMEND
